首页 产品目录 分子砌块 按反应类型 1,2,3-三唑 盐酸(3S,6R,7R,22R,23S,26S,36R,38aR)-3-(2-氨基-2-氧代乙基)-10,19-二氯-44-(((2S,3R,4S,5S,6R)-3-(((2S,4S,5S,6S)-4-((2-(癸基氨基)乙基)氨基)-5-羟基-4,6-二甲基四氢-2H-吡喃-2-基)氧基)-4,5-二羟基-6-(羟甲基)四氢-2H-吡喃-2-基)氧基)-7,22,28,30,32-五羟基-6-((R)-4-甲基-2-(甲基氨基)戊烷酰胺基)-2,5,24,38,39-五氧代-29-(((膦酰甲基)氨基)甲基)-2,3,4,5,6,7,23,24,25,26,36,37,38,38a-十四氢-1H,22H-23,36-(氮杂桥甲烷基)-8,11:18,21-二亚乙烯基-13,16:31,35-二(亚甲烯基)苯并[n][1]氧杂[6,9]二氮杂环十六炔并[4,5-d][1]氧杂[7,17]二氮杂环二十四烯-26-羧酸盐酸盐

盐酸(3S,6R,7R,22R,23S,26S,36R,38aR)-3-(2-氨基-2-氧代乙基)-10,19-二氯-44-(((2S,3R,4S,5S,6R)-3-(((2S,4S,5S,6S)-4-((2-(癸基氨基)乙基)氨基)-5-羟基-4,6-二甲基四氢-2H-吡喃-2-基)氧基)-4,5-二羟基-6-(羟甲基)四氢-2H-吡喃-2-基)氧基)-7,22,28,30,32-五羟基-6-((R)-4-甲基-2-(甲基氨基)戊烷酰胺基)-2,5,24,38,39-五氧代-29-(((膦酰甲基)氨基)甲基)-2,3,4,5,6,7,23,24,25,26,36,37,38,38a-十四氢-1H,22H-23,36-(氮杂桥甲烷基)-8,11:18,21-二亚乙烯基-13,16:31,35-二(亚甲烯基)苯并[n][1]氧杂[6,9]二氮杂环十六炔并[4,5-d][1]氧杂[7,17]二氮杂环二十四烯-26-羧酸盐酸盐

(3S,6R,7R,22R,23S,26S,36R,38aR)-3-(2-amino-2-oxoethyl)-10,19-dichloro-44-(((2S,3R,4S,5S,6R)-3-(((2S,4S,5S,6S)-4-((2-(decylamino)ethyl)amino)-5-hydroxy-4,6-dimethyltetrahydro-2H-pyran-2-yl)oxy)-4,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)-7,22,28,30,32-pentahydroxy-6-((R)-4-methyl-2-(methylamino)pentanamido)-2,5,24,38,39-pentaoxo-29-(((phosphonomethyl)amino)methyl)-2,3,4,5,6,7,23,24,25,26,36,37,38,38a-tetradecahydro-1H,22H-23,36-(epiminomethano)-8,11:18,21-dietheno-13,16:31,35-di(metheno)benzo[n][1]oxa[6,9]diazacyclohexadecino[4,5-d][1]oxa[7,17]diazacyclotetracosine-26-carboxylic acid hydrochloride

产品编号 :
Cas No. :
包装规格 纯度 目录价 会员专享价 库存 数量

抱歉,暂无牌价信息

晶智化学产品均仅供科研使用。在任何情况下,我们均不提供用于动物或人体用途的产品或服务。

基础信息

CAS No.

560130-42-9

中文名称

盐酸(3S,6R,7R,22R,23S,26S,36R,38aR)-3-(2-氨基-2-氧代乙基)-10,19-二氯-44-(((2S,3R,4S,5S,6R)-3-(((2S,4S,5S,6S)-4-((2-(癸基氨基)乙基)氨基)-5-羟基-4,6-二甲基四氢-2H-吡喃-2-基)氧基)-4,5-二羟基-6-(羟甲基)四氢-2H-吡喃-2-基)氧基)-7,22,28,30,32-五羟基-6-((R)-4-甲基-2-(甲基氨基)戊烷酰胺基)-2,5,24,38,39-五氧代-29-(((膦酰甲基)氨基)甲基)-2,3,4,5,6,7,23,24,25,26,36,37,38,38a-十四氢-1H,22H-23,36-(氮杂桥甲烷基)-8,11:18,21-二亚乙烯基-13,16:31,35-二(亚甲烯基)苯并[n][1]氧杂[6,9]二氮杂环十六炔并[4,5-d][1]氧杂[7,17]二氮杂环二十四烯-26-羧酸盐酸盐

英文名称

(3S,6R,7R,22R,23S,26S,36R,38aR)-3-(2-amino-2-oxoethyl)-10,19-dichloro-44-(((2S,3R,4S,5S,6R)-3-(((2S,4S,5S,6S)-4-((2-(decylamino)ethyl)amino)-5-hydroxy-4,6-dimethyltetrahydro-2H-pyran-2-yl)oxy)-4,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)-7,22,28,30,32-pentahydroxy-6-((R)-4-methyl-2-(methylamino)pentanamido)-2,5,24,38,39-pentaoxo-29-(((phosphonomethyl)amino)methyl)-2,3,4,5,6,7,23,24,25,26,36,37,38,38a-tetradecahydro-1H,22H-23,36-(epiminomethano)-8,11:18,21-dietheno-13,16:31,35-di(metheno)benzo[n][1]oxa[6,9]diazacyclohexadecino[4,5-d][1]oxa[7,17]diazacyclotetracosine-26-carboxylic acid hydrochloride

别名

Telavancin hydrochloride;N3''-[2-(Decylamino)ethyl]-29-[[(phosphonomethyl)amino]methyl]vancomycin hydrochloride;PubChem ID: 9812715;Telavancin HCl;TelavancinHydrochlorid;Teravanacin hydrochloride;Terafencin hydrochloride

标准英文名

(3S,6R,7R,22R,23S,26S,36R,38aR)-3-(2-amino-2-oxoethyl)-10,19-dichloro-44-(((2S,3R,4S,5S,6R)-3-(((2S,4S,5S,6S)-4-((2-(decylamino)ethyl)amino)-5-hydroxy-4,6-dimethyltetrahydro-2H-pyran-2-yl)oxy)-4,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)-7,22,28,30,32-pentahydroxy-6-((R)-4-methyl-2-(methylamino)pentanamido)-2,5,24,38,39-pentaoxo-29-(((phosphonomethyl)amino)methyl)-2,3,4,5,6,7,23,24,25,26,36,37,38,38a-tetradecahydro-1H,22H-23,36-(epiminomethano)-8,11:18,21-dietheno-13,16:31,35-di(metheno)benzo[n][1]oxa[6,9]diazacyclohexadecino[4,5-d][1]oxa[7,17]diazacyclotetracosine-26-carboxylic acid hydrochloride

分子式

C80H107Cl3N11O27P

分子量

1792.12

精确分子量

1789.61

SMILES

CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](OC3=C4C=C5C=C3OC3=C(Cl)C=C(C=C3)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)C5=CC(O)=C(CNCP(=O)(O)O)C(O)=C5C5=CC3=CC=C5O)[C@H](O)C3=CC(Cl)=C(C=C3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O.Cl

标准SMILES

Cl.CC(C)C[C@@H](NC)C(=O)N[C@@H]1[C@H](O)C2C=CC(OC3=CC4=CC(OC5C=CC(=CC=5Cl)[C@@H](O)[C@@H]5NC(=O)[C@H](NC(=O)[C@@H]4NC(=O)[C@H](CC(N)=O)NC1=O)C1=CC=C(O)C(=C1)C1C(=CC(O)=C(CNCP(O)(O)=O)C=1O)[C@H](NC5=O)C(O)=O)=C3O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O[C@H]1C[C@](C)(NCCNCCCCCCCCCC)[C@H](O)[C@H](C)O1)=C(Cl)C=2

用途

Telavancin hydrochloride is a bactericidal antibiotic developed specifically for the treatment of serious infections caused by Staphylococcus aureus and other Gram-positive bacteria, with a dual mechanism of action involving inhibition of bacterial cell wall synthesis and disruption of bacterial cell membrane function. It has been approved in the United States and Canada for the treatment of complicated skin and skin structure infections (cSSSI) caused by susceptible isolates of the following Gram-positive microorganisms: Staphylococcus aureus (including both methicillin-susceptible and methicillin-resistant strains), Streptococcus pyogenes, Streptococcus agalactiae, Streptococcus anginosus group (including Streptococcus anginosus, Streptococcus intermedius, and Streptococcus constellatus), and Enterococcus faecalis (vancomycin-susceptible isolates only).

InChIKey

GSSIWSIRBWAZHG-ACOPVEIWSA-N

安全信息

SureRoute逆合成路线

1.  560130-42-9 逆合成路线 1

—
—
ACODDR455
560130-42-9
来源: SureRoute

2.  560130-42-9 逆合成路线 2

—
—
ACODDR455
560130-42-9
来源: SureRoute

3.  560130-42-9 逆合成路线 3

—
—
ACODDR455
560130-42-9
来源: SureRoute
评论 0
我是晶智Agent,
您的化学小助手